Tissue factor-dependent chemokine production aggravates experimental colitis.

Area of Science:

• Immunology
• Gastroenterology
• Hematology

Background:

• Tissue factor (TF) initiates blood coagulation but also contributes to inflammatory processes.
• Inflammatory bowel disease (IBD) involves coagulation pathways, necessitating investigation into TF's role.
• Experimental colitis models are crucial for understanding IBD pathogenesis.

Purpose of the Study:

• To investigate the impact of genetic TF deficiency on experimental colitis severity.
• To elucidate the mechanisms by which TF influences leukocyte recruitment and inflammation in colitis.
• To determine if TF's role in colitis is mediated by its procoagulant activity or other signaling pathways.

Main Methods:

• Utilized wild-type and TF-deficient (TFlow) mice treated with dextran sulfate sodium (DSS) to induce experimental colitis.
• Assessed clinical and histological parameters of colitis severity, including edema and granulocyte infiltration.
• Measured cytokine production and examined granulocyte migration capacity and chemoattractant levels (KC).

Main Results:

• TFlow mice exhibited reduced colitis severity, with decreased edema, granulocyte numbers, and cytokine levels.
• Anticoagulant treatment in wild-type mice reduced fibrin and cytokines but did not ameliorate colitis symptoms.
• TF deficiency impaired granulocyte migration to the colon by reducing keratinocyte-derived chemokine (KC) levels, independent of intrinsic granulocyte migration capacity.

Conclusions:

• TF plays a detrimental role in experimental colitis, independent of its procoagulant function.
• TF promotes granulocyte influx into the colon via signal transduction-dependent KC production in epithelial cells.
• Targeting TF signaling may offer a therapeutic strategy for inflammatory bowel disease.